Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 28.87% ...
H.C. Wainwright has recently reiterated Microbot Medical Inc (MBOT) stock to Buy rating, as announced on January 13, 2020, according to Finviz. Earlier, on December 24, 2019, H.C. Wainwright had ...
H.C. Wainwright reaffirmed its Buy rating on Cybin Inc. (NYSE:CYBN) with a steady price target of $190.00, significantly above the current trading price of $9.59. With a market capitalization of $192 ...
Personalis (NASDAQ:PSNL – Free Report) had its price objective decreased by HC Wainwright from $11.00 to $8.00 in a research report sent to investors on Monday morning,Benzinga reports. HC Wainwright ...
Investment analysts at HC Wainwright issued their FY2024 earnings per share estimates for Genmab A/S in a report issued on ...
H.C. Wainwright raised the firm’s price target on Akero Therapeutics (AKRO) to $72 from $50 and keeps a Buy rating on the shares after the ...
H.C. Wainwright analyst Patrick Trucchio reiterates a Buy rating and $190 price target on Cybin (CYBN) shares, telling investors in a research ...